![Eric Benevich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Benevich
Direktor/Vorstandsmitglied bei
ATYR PHARMA, INC.
Vermögen: 10 Mio $ am 31.05.2026
Profil
Eric S.
Benevich is currently an Independent Director at aTyr Pharma, Inc. since 2024 and Chief Commercial Officer at Neurocrine Biosciences, Inc. since 2015.
Former roles include Senior Director-Marketing at Peninsula Pharmaceuticals, Inc. and Vice President-Communications & Marketing at Avanir Pharmaceuticals, Inc. from 2011 to 2015.
Education includes undergraduate studies at Washington State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 63’333 ( 0.06% ) | 10 Mio $ | 31.05.2026 | |
ATYR PHARMA, INC. -.--% | 11.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Eric Benevich
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.05.2015 |
| ATYR PHARMA, INC. | Direktor/Vorstandsmitglied | 10.12.2024 |
Ehemalige bekannte Positionen von Eric Benevich
| Unternehmen | Position | Ende |
|---|---|---|
| AVANIR PHARMACEUTICALS INC | Public Communications Contact | 01.01.2015 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Vertrieb & Marketing | - |
Ausbildung von Eric Benevich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
